A phase 2/3 study of ALG-1007 in the patients with Dry-eyes
Latest Information Update: 28 Jul 2021
At a glance
- Drugs ALG 1007 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 28 Jul 2021 New trial record
- 24 Jul 2021 According to an Allegro Ophthalmics media release, the U.S. Food and Drug Administration (FDA) accepted the filing of an Investigational New Drug (IND) application for this trial.